Company Overview of Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. Its product portfolio includes ORMD-0801, an oral insulin capsule that completed Phase IIa clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which is in pre-clinical trials for the treatment of type 2 diabetes. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in Jerusalem, Israel.
Hi-Tech Park 2/4
PO Box 39098
Founded in 2002
972 2 566 0001
972 2 566 0004
Key Executives for Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. Key Developments
Similar Private Companies By Industry
|Obecure Ltd.||Middle East/Africa|
|Iluten Ltd.||Middle East/Africa|
|MinoGuard Ltd.||Middle East/Africa|
|DiaLean Ltd.||Middle East/Africa|
|SimeTRA Pharm Ltd.||Middle East/Africa|
Recent Private Companies Transactions
November 3, 2014
To contact Oramed Pharmaceuticals Inc., please visit www.oramed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.